Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02826161
Title A Study of Napabucasin (BBI-608) Plus Weekly Paclitaxel Versus Weekly Paclitaxel Alone in Patients With Advanced, Previously Treated, Non-Squamous Non-Small Cell Lung Cancer (CanStem43L)
Acronym CanStem43L
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements No
Sponsors Boston Biomedical, Inc
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Beverly Hills California United States Details
Santa Rosa California United States Details
Aventura Florida United States Details
Gettysburg Pennsylvania United States Details
Arlington Texas United States Details
*Shaded cells indicate that there was no data available from for the field